Kristina Maas‐Bauer

1.4k total citations
21 papers, 557 citations indexed

About

Kristina Maas‐Bauer is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Kristina Maas‐Bauer has authored 21 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Oncology and 9 papers in Hematology. Recurrent topics in Kristina Maas‐Bauer's work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (13 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Kristina Maas‐Bauer is often cited by papers focused on Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (13 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Kristina Maas‐Bauer collaborates with scholars based in United States, Germany and Switzerland. Kristina Maas‐Bauer's co-authors include Robert S. Negrin, Robert Zeiser, Melissa Mavers, Jürgen Finke, Mareike Verbeek, Michael Bscheider, Annette Schmitt‐Graeff, Nikolas von Bubnoff, Julius Fischer and Justus Duyster and has published in prestigious journals such as Blood, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Kristina Maas‐Bauer

17 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Maas‐Bauer United States 9 337 319 176 113 55 21 557
Hélène Trebeden‐Negre France 14 305 0.9× 165 0.5× 167 0.9× 94 0.8× 94 1.7× 19 544
David B. Miklos United States 4 351 1.0× 537 1.7× 122 0.7× 94 0.8× 39 0.7× 14 684
Chiharu Sugimori Japan 14 435 1.3× 525 1.6× 90 0.5× 146 1.3× 44 0.8× 34 739
Edward S. Morris Australia 15 691 2.1× 623 2.0× 190 1.1× 73 0.6× 76 1.4× 25 958
Nimitha R. Mathew Sweden 6 232 0.7× 240 0.8× 80 0.5× 114 1.0× 84 1.5× 7 436
Laura Montiel‐Cervantes Mexico 12 208 0.6× 243 0.8× 132 0.8× 91 0.8× 102 1.9× 35 469
James Morton Australia 12 136 0.4× 329 1.0× 134 0.8× 85 0.8× 64 1.2× 22 464
Maria Spyropoulou‐Vlachou Greece 13 368 1.1× 239 0.7× 138 0.8× 55 0.5× 189 3.4× 26 676
Michelle Abboud United States 8 207 0.6× 367 1.2× 114 0.6× 173 1.5× 63 1.1× 15 535
Rudolf Peceny Germany 13 358 1.1× 587 1.8× 108 0.6× 159 1.4× 153 2.8× 20 822

Countries citing papers authored by Kristina Maas‐Bauer

Since Specialization
Citations

This map shows the geographic impact of Kristina Maas‐Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Maas‐Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Maas‐Bauer more than expected).

Fields of papers citing papers by Kristina Maas‐Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Maas‐Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Maas‐Bauer. The network helps show where Kristina Maas‐Bauer may publish in the future.

Co-authorship network of co-authors of Kristina Maas‐Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Maas‐Bauer. A scholar is included among the top collaborators of Kristina Maas‐Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Maas‐Bauer. Kristina Maas‐Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biavasco, Francesca, Johannes Clausen, Johannes Jung, et al.. (2025). Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey. Bone Marrow Transplantation. 60(6). 873–878.
2.
Bertz, Hartmut, Donald C. McMillan, Claudia Wehr, et al.. (2025). The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation. British Journal of Haematology. 207(4). 1517–1528.
3.
Duque‐Afonso, Jesús, Gabriele Ihorst, Claudia Wehr, et al.. (2024). Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens. Bone Marrow Transplantation. 59(12). 1744–1753.
4.
Kelly, Katherine J., et al.. (2024). Genocopy of EVI1-AML with Paraneoplastic Diabetes Insipidus: PRDM16 Overexpression By t(1;2) and Enhancer Hijacking. Blood. 144(Supplement 1). 6136–6136.
5.
Meyer, Thomas, Kristina Maas‐Bauer, Ralph Wäsch, et al.. (2024). Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis. Bone Marrow Transplantation. 60(3). 286–296. 2 indexed citations
6.
Maas‐Bauer, Kristina, Natalie Köhler, Melissa Zwick, et al.. (2023). Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cells. Journal of Leukocyte Biology. 115(2). 401–409. 5 indexed citations
7.
Simonetta, Federico, Juliane K. Lohmeyer, Toshihito Hirai, et al.. (2021). Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming. Clinical Cancer Research. 27(21). 6054–6064. 44 indexed citations
8.
Maas‐Bauer, Kristina, Juliane K. Lohmeyer, Toshihito Hirai, et al.. (2021). Invariant natural killer T-cell subsets have diverse graft-versus-host-disease–preventing and antitumor effects. Blood. 138(10). 858–870. 20 indexed citations
9.
Hirai, Toshihito, Po‐Yu Lin, Federico Simonetta, et al.. (2021). Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD. Blood Advances. 5(11). 2528–2538. 9 indexed citations
10.
Álvarez, Maite, Antonio Pierini, Federico Simonetta, et al.. (2021). Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology. 11. 5 indexed citations
11.
Maas‐Bauer, Kristina, Hartmut Bertz, Petya Apostolova, et al.. (2020). Ruxolitinib–ECP combination treatment for refractory severe chronic graft-versus-host disease. Bone Marrow Transplantation. 56(4). 909–916. 39 indexed citations
12.
Simonetta, Federico, Toshihito Hirai, Juliane K. Lohmeyer, et al.. (2020). Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming. Biology of Blood and Marrow Transplantation. 26(3). S42–S42. 1 indexed citations
13.
Mavers, Melissa, Federico Simonetta, Hidekazu Nishikii, et al.. (2019). Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease. Frontiers in Immunology. 10. 1624–1624. 17 indexed citations
14.
Mavers, Melissa, Federico Simonetta, Alexander Lee, et al.. (2018). IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells. Biology of Blood and Marrow Transplantation. 24(3). S208–S209. 2 indexed citations
15.
Mavers, Melissa, Federico Simonetta, Alexander Lee, et al.. (2017). IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells. Blood. 130. 3199–3199. 1 indexed citations
16.
Mavers, Melissa, Kristina Maas‐Bauer, & Robert S. Negrin. (2017). Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 8. 900–900. 50 indexed citations
17.
Nishikii, Hidekazu, Yasuhisa Yokoyama, Yan Chen, et al.. (2016). DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease. Blood. 128(24). 2846–2858. 37 indexed citations
18.
Spoerl, Silvia, Kristina Maas‐Bauer, Mareike Verbeek, et al.. (2014). Response to JAK 1/2 Inhibition in Patients with Corticosteroid-Refractory Acute Graft-Versus-Host Disease. Blood. 124(21). 3934–3934. 2 indexed citations
19.
Spoerl, Silvia, Nimitha R. Mathew, Michael Bscheider, et al.. (2014). Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease. Blood. 123(24). 3832–3842. 290 indexed citations
20.
Zeiser, Robert, Kristina Maas‐Bauer, Sawsan Youssef, et al.. (2008). Regulation of different inflammatory diseases by impacting the mevalonate pathway. Immunology. 127(1). 18–25. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Trebeden‐Negre Breakdown of academic impact, for papers by David B. Miklos Breakdown of academic impact, for papers by Chiharu Sugimori Breakdown of academic impact, for papers by Edward S. Morris Breakdown of academic impact, for papers by Nimitha R. Mathew Breakdown of academic impact, for papers by Laura Montiel‐Cervantes Breakdown of academic impact, for papers by James Morton Breakdown of academic impact, for papers by Maria Spyropoulou‐Vlachou Breakdown of academic impact, for papers by Michelle Abboud Breakdown of academic impact, for papers by Rudolf Peceny
Rankless by CCL
2026